{"transactions":[{"id":4634934,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2026-09-30T21:14:56.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":113896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests infour equal quarterly installments."}],"balance_after":113896,"derivative":{"exercise_price":0.5,"expiration_date":"2036-09-28","underlying":"Common Stock","underlying_shares":113896},"source":{"system":"sec-edgar","filing":"0001493152-26-045149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226045149/ownership.xml","form_type":"4"}},{"id":4634927,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78780,"kind":"person","name":"Angle Siddhesh Rajendra","position":1,"cik":"0001889218","reported_name":"Angle Siddhesh Rajendra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2026-09-30T21:12:42.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":113896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests infour equal quarterly installments."}],"balance_after":113896,"derivative":{"exercise_price":0.5,"expiration_date":"2036-09-28","underlying":"Common Stock","underlying_shares":113896},"source":{"system":"sec-edgar","filing":"0001493152-26-045147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226045147/ownership.xml","form_type":"4"}},{"id":4634162,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78808,"kind":"person","name":"Meikle Phillip Terry II","position":1,"cik":"0002041874","reported_name":"Meikle Phillip Terry II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2026-09-30T21:09:07.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":113896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests infour equal quarterly installments."}],"balance_after":113896,"derivative":{"exercise_price":0.5,"expiration_date":"2036-09-28","underlying":"Common Stock","underlying_shares":113896},"source":{"system":"sec-edgar","filing":"0001493152-26-045140","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2041874/000149315226045140/ownership.xml","form_type":"4"}},{"id":4634933,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78781,"kind":"person","name":"Stroever Bruce","position":1,"cik":"0001657728","reported_name":"Stroever Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2026-09-30T21:06:43.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":113896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests infour equal quarterly installments."}],"balance_after":113896,"derivative":{"exercise_price":0.5,"expiration_date":"2036-09-28","underlying":"Common Stock","underlying_shares":113896},"source":{"system":"sec-edgar","filing":"0001493152-26-045135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226045135/ownership.xml","form_type":"4"}},{"id":934147,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2026-01-21T21:37:13.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":16668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":16668,"derivative":{"exercise_price":1.55,"exercise_date":"2026-01-08","expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":16668},"source":{"system":"sec-edgar","filing":"0001493152-26-003102","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226003102/ownership.xml","form_type":"4"}},{"id":934206,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2026-01-21T16:37:14.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":8335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":8335,"derivative":{"exercise_price":1.55,"exercise_date":"2026-01-08","expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":8335},"source":{"system":"sec-edgar","filing":"0001493152-26-003103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315226003103/ownership.xml","form_type":"4"}},{"id":1119459,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78780,"kind":"person","name":"Angle Siddhesh Rajendra","position":1,"cik":"0001889218","reported_name":"Angle Siddhesh Rajendra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2025-06-06T21:01:24.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":62894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments."}],"balance_after":62894,"derivative":{"exercise_price":0.88,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":62894},"source":{"system":"sec-edgar","filing":"0001641172-25-014097","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225014097/ownership.xml","form_type":"4"}},{"id":1119461,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78781,"kind":"person","name":"Stroever Bruce","position":1,"cik":"0001657728","reported_name":"Stroever Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2025-06-06T21:01:18.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":62894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments."}],"balance_after":62894,"derivative":{"exercise_price":0.88,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":62894},"source":{"system":"sec-edgar","filing":"0001641172-25-014100","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225014100/ownership.xml","form_type":"4"}},{"id":1119458,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2025-06-06T21:01:12.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":62894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments."}],"balance_after":62894,"derivative":{"exercise_price":0.88,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":62894},"source":{"system":"sec-edgar","filing":"0001641172-25-014098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225014098/ownership.xml","form_type":"4"}},{"id":1120026,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78808,"kind":"person","name":"Meikle Phillip Terry II","position":1,"cik":"0002041874","reported_name":"Meikle Phillip Terry II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2025-06-06T17:01:30.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":62894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments."}],"balance_after":62894,"derivative":{"exercise_price":0.88,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":62894},"source":{"system":"sec-edgar","filing":"0001641172-25-014099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2041874/000164117225014099/ownership.xml","form_type":"4"}},{"id":1298704,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2025-01-21T11:10:12.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":54110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice,vests and becomes exercisable immediately."}],"balance_after":54110,"derivative":{"exercise_price":0.9678,"exercise_date":"2025-01-15","expiration_date":"2027-01-15","underlying":"Common Stock","underlying_shares":54110},"source":{"system":"sec-edgar","filing":"0001493152-25-002884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315225002884/ownership.xml","form_type":"4"}},{"id":1298769,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2025-01-21T06:06:14.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":27055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":27055,"derivative":{"exercise_price":0.9678,"exercise_date":"2025-01-15","expiration_date":"2027-01-15","underlying":"Common Stock","underlying_shares":27055},"source":{"system":"sec-edgar","filing":"0001493152-25-002880","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315225002880/ownership.xml","form_type":"4"}},{"id":1384262,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78808,"kind":"person","name":"Meikle Phillip Terry II","position":1,"cik":"0002041874","reported_name":"Meikle Phillip Terry II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2024-10-18T20:27:04.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":28185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vesting and becoming exercisable in four equal installments on 12/17/24, 3/19/25, 6/19/25 and 9/17/25."}],"balance_after":28185,"derivative":{"exercise_price":1.88,"expiration_date":"2034-10-16","underlying":"Common Stock","underlying_shares":28185},"source":{"system":"sec-edgar","filing":"0001493152-24-041658","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2041874/000149315224041658/ownership.xml","form_type":"4"}},{"id":1384261,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78808,"kind":"person","name":"Meikle Phillip Terry II","position":1,"cik":"0002041874","reported_name":"Meikle Phillip Terry II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2024-10-18T20:27:04.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":9,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable on the date of the next annual meeting of the stockholders of the Company following the grant date."}],"balance_after":9,"derivative":{"exercise_price":1.88,"expiration_date":"2034-10-16","underlying":"Common Stock","underlying_shares":9},"source":{"system":"sec-edgar","filing":"0001493152-24-041658","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2041874/000149315224041658/ownership.xml","form_type":"4"}},{"id":1402261,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78781,"kind":"person","name":"Stroever Bruce","position":1,"cik":"0001657728","reported_name":"Stroever Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2024-09-20T01:33:09.000Z","date":"2024-09-17","kind":"grant","planned":false,"acquired":true,"shares":30713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company."}],"balance_after":30713,"derivative":{"exercise_price":1.73,"expiration_date":"2034-09-17","underlying":"Common Stock","underlying_shares":30713},"source":{"system":"sec-edgar","filing":"0001493152-24-037222","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224037222/ownership.xml","form_type":"4"}},{"id":1402260,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non- Employee Stock Option","published_at":"2024-09-20T01:31:32.000Z","date":"2024-09-17","kind":"grant","planned":false,"acquired":true,"shares":30713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company."}],"balance_after":30713,"derivative":{"exercise_price":1.73,"expiration_date":"2034-09-17","underlying":"Common Stock","underlying_shares":30713},"source":{"system":"sec-edgar","filing":"0001493152-24-037220","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224037220/ownership.xml","form_type":"4"}},{"id":1402259,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78780,"kind":"person","name":"Angle Siddhesh Rajendra","position":1,"cik":"0001889218","reported_name":"Angle Siddhesh Rajendra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2024-09-20T01:29:45.000Z","date":"2024-09-17","kind":"grant","planned":false,"acquired":true,"shares":30713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company."}],"balance_after":30713,"derivative":{"exercise_price":1.73,"expiration_date":"2034-09-17","underlying":"Common Stock","underlying_shares":30713},"source":{"system":"sec-edgar","filing":"0001493152-24-037218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224037218/ownership.xml","form_type":"4"}},{"id":1675114,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2024-01-19T22:22:54.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":25000,"derivative":{"exercise_price":3.61,"exercise_date":"2024-01-17","expiration_date":"2026-01-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-003097","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224003097/ownership.xml","form_type":"4"}},{"id":1675196,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2024-01-19T17:24:01.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":12500,"derivative":{"exercise_price":3.61,"exercise_date":"2024-01-17","expiration_date":"2026-01-17","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-24-003099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315224003099/ownership.xml","form_type":"4"}},{"id":1681521,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2024-01-10T22:17:09.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":8.006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, 2,003 options are immediately exercisable with the remaining 6,003 options vesting and becoming exercisable in three equal installments on 3/12/2024, 6/12/2024, and 9/12/2024."}],"balance_after":8015,"derivative":{"exercise_price":4.68,"expiration_date":"2034-01-08","underlying":"Common Stock","underlying_shares":8006},"source":{"system":"sec-edgar","filing":"0001493152-24-001971","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224001971/ownership.xml","form_type":"4"}},{"id":1681520,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2024-01-10T22:17:09.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":9,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable on the date of the next annual meeting of the stockholders of the Company following the grant date."}],"balance_after":9,"derivative":{"exercise_price":4.68,"expiration_date":"2034-01-08","underlying":"Common Stock","underlying_shares":9},"source":{"system":"sec-edgar","filing":"0001493152-24-001971","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224001971/ownership.xml","form_type":"4"}},{"id":1776120,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-09-20T18:54:16.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":85763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":85763,"derivative":{"exercise_price":0.64,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":85763},"source":{"system":"sec-edgar","filing":"0001493152-23-033177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223033177/ownership.xml","form_type":"4"}},{"id":1776119,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78780,"kind":"person","name":"Angle Siddhesh Rajendra","position":1,"cik":"0001889218","reported_name":"Angle Siddhesh Rajendra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-09-20T18:54:14.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":85763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":85763,"derivative":{"exercise_price":0.64,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":85763},"source":{"system":"sec-edgar","filing":"0001493152-23-033176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223033176/ownership.xml","form_type":"4"}},{"id":1776118,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78781,"kind":"person","name":"Stroever Bruce","position":1,"cik":"0001657728","reported_name":"Stroever Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-09-20T18:54:11.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":85763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":85763,"derivative":{"exercise_price":0.64,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":85763},"source":{"system":"sec-edgar","filing":"0001493152-23-033175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223033175/ownership.xml","form_type":"4"}},{"id":1781035,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T11:08:08.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":0.64,"value":5120.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-23-032583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223032583/ownership.xml","form_type":"4"}},{"id":1782855,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-12T15:34:57.000Z","date":"2023-09-11","kind":"purchase","planned":false,"acquired":true,"shares":9500,"price":0.6874,"value":6530.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6898, inclusive. Mr. Frelick undertakes to provide Bone Biologics Corporation, any security holder of Bone Biologics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17204,"source":{"system":"sec-edgar","filing":"0001493152-23-032321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223032321/ownership.xml","form_type":"4"}},{"id":1785859,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-07T10:45:57.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":6700,"price":0.71,"value":4757.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001493152-23-031935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223031935/ownership.xml","form_type":"4"}},{"id":1785858,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-07T10:45:57.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":0.7,"value":210.0,"ownership":{"direct":true},"balance_after":300,"source":{"system":"sec-edgar","filing":"0001493152-23-031935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223031935/ownership.xml","form_type":"4"}},{"id":1789055,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-05T21:05:23.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":7600,"price":0.6605,"value":5019.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104 shares of vested restricted stock that were inadvertently reported in Table II at the time of grant."}],"balance_after":7704,"source":{"system":"sec-edgar","filing":"0001493152-23-031680","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223031680/ownership.xml","form_type":"4"}},{"id":1935949,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":115035,"kind":"organization","name":"Knight Insurance Company, Ltd","position":2,"cik":"0001971547","reported_name":"Knight Insurance Company, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2023-03-29T16:55:08.000Z","date":"2023-03-13","kind":"other","planned":false,"acquired":true,"shares":37918,"price":0.01,"value":379.18,"ownership":{"direct":false,"nature":"Knight Specialty Insurance Company"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b.\tKnight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants"}],"balance_after":37918,"derivative":{"exercise_price":6.3,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common","underlying_shares":37918},"source":{"system":"sec-edgar","filing":"0001493152-23-009491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1971547/000149315223009491/ownership.xml","form_type":"4"}},{"id":1935948,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":115035,"kind":"organization","name":"Knight Insurance Company, Ltd","position":2,"cik":"0001971547","reported_name":"Knight Insurance Company, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2023-03-29T16:55:08.000Z","date":"2023-03-13","kind":"other","planned":false,"acquired":true,"shares":19297,"price":0.01,"value":192.97,"ownership":{"direct":false,"nature":"Knightbrook Insurance Company"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b.\tKnight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants"}],"balance_after":19297,"derivative":{"exercise_price":6.3,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common","underlying_shares":19297},"source":{"system":"sec-edgar","filing":"0001493152-23-009491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1971547/000149315223009491/ownership.xml","form_type":"4"}},{"id":1935947,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":115035,"kind":"organization","name":"Knight Insurance Company, Ltd","position":2,"cik":"0001971547","reported_name":"Knight Insurance Company, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2023-03-29T16:55:08.000Z","date":"2023-03-13","kind":"other","planned":false,"acquired":true,"shares":99148,"price":0.01,"value":991.48,"ownership":{"direct":false,"nature":"Knight Insurance Company, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b.\tKnight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants"}],"balance_after":99148,"derivative":{"exercise_price":6.3,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common","underlying_shares":99148},"source":{"system":"sec-edgar","filing":"0001493152-23-009491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1971547/000149315223009491/ownership.xml","form_type":"4"}},{"id":1935946,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":115035,"kind":"organization","name":"Knight Insurance Company, Ltd","position":2,"cik":"0001971547","reported_name":"Knight Insurance Company, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2023-03-29T16:55:08.000Z","date":"2023-03-13","kind":"other","planned":false,"acquired":true,"shares":5252,"price":0.01,"value":52.52,"ownership":{"direct":false,"nature":"Knight Services, Inc"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b.\tKnight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants"}],"balance_after":5252,"derivative":{"exercise_price":6.3,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common","underlying_shares":5252},"source":{"system":"sec-edgar","filing":"0001493152-23-009491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1971547/000149315223009491/ownership.xml","form_type":"4"}},{"id":1935945,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":115035,"kind":"organization","name":"Knight Insurance Company, Ltd","position":2,"cik":"0001971547","reported_name":"Knight Insurance Company, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2023-03-29T16:55:08.000Z","date":"2023-03-13","kind":"other","planned":false,"acquired":true,"shares":280764,"price":0.01,"value":2807.64,"ownership":{"direct":false,"nature":"Don Hankey Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b.\tKnight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants"}],"balance_after":280764,"derivative":{"exercise_price":6.3,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common","underlying_shares":280764},"source":{"system":"sec-edgar","filing":"0001493152-23-009491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1971547/000149315223009491/ownership.xml","form_type":"4"}},{"id":1935944,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":115035,"kind":"organization","name":"Knight Insurance Company, Ltd","position":2,"cik":"0001971547","reported_name":"Knight Insurance Company, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2023-03-29T16:55:08.000Z","date":"2023-03-13","kind":"other","planned":false,"acquired":false,"shares":33811,"price":0.01,"value":338.11,"ownership":{"direct":false,"nature":"Hankey Capital, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b.\tKnight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants"}],"balance_after":0,"derivative":{"exercise_price":6.3,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common","underlying_shares":33811},"source":{"system":"sec-edgar","filing":"0001493152-23-009491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1971547/000149315223009491/ownership.xml","form_type":"4"}},{"id":1935943,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":115035,"kind":"organization","name":"Knight Insurance Company, Ltd","position":2,"cik":"0001971547","reported_name":"Knight Insurance Company, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T16:55:08.000Z","date":"2023-03-13","kind":"other","planned":false,"acquired":false,"shares":500137,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b.\tKnight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-23-009491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971547/000149315223009491/ownership.xml","form_type":"4"}},{"id":1963101,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78780,"kind":"person","name":"Angle Siddhesh Rajendra","position":1,"cik":"0001889218","reported_name":"Angle Siddhesh Rajendra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-03-08T11:20:31.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":36845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":68516,"derivative":{"exercise_price":1.61,"expiration_date":"2027-08-23","underlying":"Common Stock","underlying_shares":36845},"source":{"system":"sec-edgar","filing":"0001493152-23-006967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223006967/ownership.xml","form_type":"4"}},{"id":1963102,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78781,"kind":"person","name":"Stroever Bruce","position":1,"cik":"0001657728","reported_name":"Stroever Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-03-08T11:20:29.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":36845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":48516,"derivative":{"exercise_price":1.61,"expiration_date":"2027-08-23","underlying":"Common Stock","underlying_shares":36845},"source":{"system":"sec-edgar","filing":"0001493152-23-006969","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223006969/ownership.xml","form_type":"4"}},{"id":1963100,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2023-03-08T11:20:27.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":37750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":140140,"derivative":{"exercise_price":0.24,"exercise_date":"2023-01-25","expiration_date":"2025-01-25","underlying":"Common Stock","underlying_shares":37750},"source":{"system":"sec-edgar","filing":"0001493152-23-006968","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223006968/ownership.xml","form_type":"4"}},{"id":1963093,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-03-08T11:20:25.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":36845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":68516,"derivative":{"exercise_price":1.61,"expiration_date":"2027-08-23","underlying":"Common Stock","underlying_shares":36845},"source":{"system":"sec-edgar","filing":"0001493152-23-006966","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223006966/ownership.xml","form_type":"4"}},{"id":1963264,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2023-03-08T06:20:23.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":18875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43875,"derivative":{"exercise_price":0.24,"exercise_date":"2023-01-25","expiration_date":"2025-01-25","underlying":"Common Stock","underlying_shares":18875},"source":{"system":"sec-edgar","filing":"0001493152-23-006965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223006965/ownership.xml","form_type":"4"}},{"id":2368770,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2022-02-28T11:05:13.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":102389,"derivative":{"exercise_price":3.72,"exercise_date":"2022-01-01","expiration_date":"2025-01-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-005548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005548/ownership.xml","form_type":"4"}},{"id":2368769,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78780,"kind":"person","name":"Angle Siddhesh Rajendra","position":1,"cik":"0001889218","reported_name":"Angle Siddhesh Rajendra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:03:57.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":8722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":31671,"derivative":{"exercise_price":3.52,"expiration_date":"2032-01-01","underlying":"Common Stock","underlying_shares":8722},"source":{"system":"sec-edgar","filing":"0001493152-22-005546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005546/ownership.xml","form_type":"4"}},{"id":2368768,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78780,"kind":"person","name":"Angle Siddhesh Rajendra","position":1,"cik":"0001889218","reported_name":"Angle Siddhesh Rajendra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:03:57.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22949,"derivative":{"exercise_price":5.25,"exercise_date":"2021-12-31","expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":2949},"source":{"system":"sec-edgar","filing":"0001493152-22-005546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005546/ownership.xml","form_type":"4"}},{"id":2368767,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78781,"kind":"person","name":"Stroever Bruce","position":1,"cik":"0001657728","reported_name":"Stroever Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:03:06.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":8722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the\nCompany following the Grant."}],"balance_after":11671,"derivative":{"exercise_price":3.52,"expiration_date":"2032-01-01","underlying":"Common Stock","underlying_shares":8722},"source":{"system":"sec-edgar","filing":"0001493152-22-005545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005545/ownership.xml","form_type":"4"}},{"id":2368766,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":78781,"kind":"person","name":"Stroever Bruce","position":1,"cik":"0001657728","reported_name":"Stroever Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:03:06.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2949,"derivative":{"exercise_price":5.25,"exercise_date":"2021-12-31","expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":2949},"source":{"system":"sec-edgar","filing":"0001493152-22-005545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005545/ownership.xml","form_type":"4"}},{"id":2368761,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:02:06.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":8722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant."}],"balance_after":31671,"derivative":{"exercise_price":3.52,"expiration_date":"2032-01-01","underlying":"Common Stock","underlying_shares":8722},"source":{"system":"sec-edgar","filing":"0001493152-22-005543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005543/ownership.xml","form_type":"4"}},{"id":2368760,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22905,"kind":"person","name":"Lucera Erick","position":1,"cik":"0001697616","reported_name":"Lucera Erick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-02-28T11:02:06.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22949,"derivative":{"exercise_price":5.25,"exercise_date":"2021-12-31","expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":2949},"source":{"system":"sec-edgar","filing":"0001493152-22-005543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005543/ownership.xml","form_type":"4"}},{"id":2369041,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2022-02-28T06:04:31.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.72,"exercise_date":"2022-01-03","expiration_date":"2025-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-005547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315222005547/ownership.xml","form_type":"4"}},{"id":2539139,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2021-10-20T00:17:44.000Z","date":"2021-10-15","kind":"other","acquired":true,"shares":476190,"price":0.01,"value":4761.9,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares purchased in the Issuer's public offering of units, with each unit consisting of one share of Common Stock and one Warrant. The allocation of a unit is $5.24 for a common share, and $0.01 for a warrant."}],"balance_after":476190,"derivative":{"exercise_price":6.3,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common","underlying_shares":476190},"source":{"system":"sec-edgar","filing":"0001493152-21-025816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315221025816/ownership.xml","form_type":"4"}},{"id":2539138,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T00:17:44.000Z","date":"2021-10-15","kind":"gift","acquired":false,"shares":1004310,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"BY HANKEY CAPITAL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares gifted to third parties."}],"balance_after":7025802,"source":{"system":"sec-edgar","filing":"0001493152-21-025816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315221025816/ownership.xml","form_type":"4"}},{"id":2539137,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T00:17:44.000Z","date":"2021-10-15","kind":"other","acquired":true,"shares":476190,"price":5.24,"value":2495235.6,"ownership":{"direct":false,"nature":"BY HANKEY CAPITAL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares purchased in the Issuer's public offering of units, with each unit consisting of one share of Common Stock and one Warrant. The allocation of a unit is $5.24 for a common share, and $0.01 for a warrant."}],"balance_after":8030112,"source":{"system":"sec-edgar","filing":"0001493152-21-025816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315221025816/ownership.xml","form_type":"4"}},{"id":2539136,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T00:17:44.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":9361702,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"BY HANKEY CAPITAL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents cancelation of collateral shares issued to secure the debt."}],"balance_after":7553922,"source":{"system":"sec-edgar","filing":"0001493152-21-025816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315221025816/ownership.xml","form_type":"4"}},{"id":2539135,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T00:17:44.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":5928774,"price":2.5,"value":14821935.0,"ownership":{"direct":false,"nature":"BY HANKEY CAPITAL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares issued upon conversion of debt at a conversion rate of $2.50 per share."}],"balance_after":16915624,"source":{"system":"sec-edgar","filing":"0001493152-21-025816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315221025816/ownership.xml","form_type":"4"}},{"id":3307713,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":152308,"kind":"person","name":"Hankey Bret","position":1,"cik":"0001747562","reported_name":"Hankey Bret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-17T22:24:52.000Z","date":"2020-01-02","kind":"purchase","acquired":true,"shares":195000,"price":1,"value":195000.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares transferred from H&H Funding LLC to Hankey Capital LLC (\"Hankey Capital\"). Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Bret Hankey Trust (the \"Bret Trust\") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the \"RB Trust\") owns a 0.94% interest and the Hankey Children's Trust (the \"Children's Trust\") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."}],"balance_after":28122518,"source":{"system":"sec-edgar","filing":"0001493152-20-000776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315220000776/ownership.xml","form_type":"4"}},{"id":3307727,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152309,"kind":"organization","name":"Don Hankey Trust","position":3,"cik":"0001747743","reported_name":"Don Hankey Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"affiliate of 10% owner/dir"}}],"security":"Common Stock","published_at":"2020-01-17T22:22:41.000Z","date":"2020-01-02","kind":"purchase","acquired":true,"shares":195000,"price":1,"value":195000.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares transferred from H&H Funding LLC (\"H&H\") to Hankey Capital LLC (\"Hankey Capital\"). Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Don Hankey Trust (the \"Trust\") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey is the sole manager of H&H. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital and H&H except to the extent of his pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mr. Hankey is the beneficial owner of 28,563,398 shares of the Company consisting of 4,062,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 335,000 shares issuable to Hankey Capital upon conversion of debt, 361,640 shares owned by the Don Hankey Trust (the \"Trust\") of which Mr. Hankey is the Trustee, 79,240 shares held by H&H Funding LLC and 320,393 shares issuable upon exercise of warrants issued to Hankey Capital."}],"balance_after":28563398,"source":{"system":"sec-edgar","filing":"0001493152-20-000773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315220000773/ownership.xml","form_type":"4"}},{"id":3443446,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":152308,"kind":"person","name":"Hankey Bret","position":1,"cik":"0001747562","reported_name":"Hankey Bret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-08T17:47:36.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":553191,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender."},{"field":"shares","element":"transactionShares","label":"F2","text":"Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Bret Hankey Trust (the \"Bret Trust\") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the \"RB Trust\") owns a 0.94% interest and the Hankey Children's Trust (the \"Children's Trust\") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."}],"balance_after":27829860,"source":{"system":"sec-edgar","filing":"0001493152-19-011867","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219011867/ownership.xml","form_type":"4"}},{"id":3443445,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152309,"kind":"organization","name":"Don Hankey Trust","position":3,"cik":"0001747743","reported_name":"Don Hankey Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"affiliate of 10% owner/dir"}}],"security":"Common Stock","published_at":"2019-08-08T17:46:09.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":553191,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Don Hankey Trust (the \"Trust\") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mr. Hankey is the beneficial owner of 28,465,740 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the \"Trust\") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital."}],"balance_after":28465740,"source":{"system":"sec-edgar","filing":"0001493152-19-011866","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219011866/ownership.xml","form_type":"4"}},{"id":3459824,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152309,"kind":"organization","name":"Don Hankey Trust","position":3,"cik":"0001747743","reported_name":"Don Hankey Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"affiliate of 10% owner/dir"}}],"security":"Common Stock","published_at":"2019-07-17T18:05:41.000Z","date":"2019-07-15","kind":"purchase","acquired":true,"shares":85106,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Don Hankey Trust (the \"Trust\") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mr. Hankey is the beneficial owner of 27,912,549 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 22,851,064 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the \"Trust\") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital."}],"balance_after":27912549,"source":{"system":"sec-edgar","filing":"0001493152-19-010727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219010727/ownership.xml","form_type":"4"}},{"id":3459821,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":152308,"kind":"person","name":"Hankey Bret","position":1,"cik":"0001747562","reported_name":"Hankey Bret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T17:55:07.000Z","date":"2019-07-15","kind":"purchase","acquired":true,"shares":85106,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"BY HANKEY CAPITAL, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender."},{"field":"shares","element":"transactionShares","label":"F2","text":"Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Bret Hankey Trust (the \"Bret Trust\") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the \"RB Trust\") owns a 0.94% interest and the Hankey Children's Trust (the \"Children's Trust\") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F3","text":"Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."}],"source":{"system":"sec-edgar","filing":"0001493152-19-010724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219010724/ownership.xml","form_type":"4"}},{"id":3481226,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152309,"kind":"organization","name":"Don Hankey Trust","position":3,"cik":"0001747743","reported_name":"Don Hankey Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"affiliate of 10% owner/dir"}}],"security":"Common Stock","published_at":"2019-06-21T19:39:28.000Z","date":"2019-06-20","kind":"purchase","acquired":true,"shares":1063830,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Don Hankey Trust (the \"Trust\") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F2","text":"Mr. Hankey is the beneficial owner of 27,827,443 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 22,765,958 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the \"Trust\") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital."}],"source":{"system":"sec-edgar","filing":"0001493152-19-009561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219009561/ownership.xml","form_type":"4"}},{"id":3481223,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":152308,"kind":"person","name":"Hankey Bret","position":1,"cik":"0001747562","reported_name":"Hankey Bret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T19:37:45.000Z","date":"2019-06-20","kind":"purchase","acquired":true,"shares":1063830,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender."},{"field":"shares","element":"transactionShares","label":"F2","text":"Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Bret Hankey Trust (the \"Bret Trust\") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the \"RB Trust\") owns a 0.94% interest and the Hankey Children's Trust (the \"Children's Trust\") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."}],"balance_after":27191563,"source":{"system":"sec-edgar","filing":"0001493152-19-009559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219009559/ownership.xml","form_type":"4"}},{"id":3511659,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152309,"kind":"organization","name":"Don Hankey Trust","position":3,"cik":"0001747743","reported_name":"Don Hankey Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"affiliate of 10% owner/dir"}}],"security":"Common Stock","published_at":"2019-05-24T18:07:25.000Z","date":"2019-05-07","kind":"purchase","acquired":true,"shares":1063830,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Don Hankey Trust (the \"Trust\") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mr. Hankey is the beneficial owner of 26,763,613 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 21,702,128 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the \"Trust\") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital."}],"balance_after":26763613,"source":{"system":"sec-edgar","filing":"0001493152-19-008227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219008227/ownership.xml","form_type":"4"}},{"id":3511658,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":152308,"kind":"person","name":"Hankey Bret","position":1,"cik":"0001747562","reported_name":"Hankey Bret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-24T18:05:45.000Z","date":"2019-05-07","kind":"purchase","acquired":true,"shares":1063830,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender."},{"field":"shares","element":"transactionShares","label":"F2","text":"Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Bret Hankey Trust (the \"Bret Trust\") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the \"RB Trust\") owns a 0.94% interest and the Hankey Children's Trust (the \"Children's Trust\") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."}],"balance_after":26127733,"source":{"system":"sec-edgar","filing":"0001493152-19-008226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219008226/ownership.xml","form_type":"4"}},{"id":3551041,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":158193,"kind":"person","name":"Booth John J","position":1,"cik":"0001655227","reported_name":"Booth John J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2019-04-23T16:05:21.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":54909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four (4) successive equal quarterly installments over the one year period measured from the date of grant."}],"balance_after":67054,"derivative":{"exercise_price":0.94,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":54909},"source":{"system":"sec-edgar","filing":"0001493152-19-005760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219005760/ownership.xml","form_type":"4"}},{"id":3578363,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":152308,"kind":"person","name":"Hankey Bret","position":1,"cik":"0001747562","reported_name":"Hankey Bret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-26T19:37:25.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":1489362,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"BY HANKEY CAPITAL, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender."},{"field":"shares","element":"transactionShares","label":"F2","text":"Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Bret Hankey Trust (the \"Bret Trust\") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the \"RB Trust\") owns a 0.94% interest and the Hankey Children's Trust (the \"Children's Trust\") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of shares held by Hankey Capital. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."}],"balance_after":25063903,"source":{"system":"sec-edgar","filing":"0001493152-19-003934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219003934/ownership.xml","form_type":"4"}},{"id":3578362,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":152308,"kind":"person","name":"Hankey Bret","position":1,"cik":"0001747562","reported_name":"Hankey Bret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-26T19:37:25.000Z","date":"2018-12-17","kind":"purchase","acquired":true,"shares":18009696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"BY HANKEY CAPITAL, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender."},{"field":"shares","element":"transactionShares","label":"F2","text":"Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Bret Hankey Trust (the \"Bret Trust\") owns a 5.83% interest, the Rufus and Bret Hankey Trust (the \"RB Trust\") owns a 0.94% interest and the Hankey Children's Trust (the \"Children's Trust\") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his or his immediate family's pecuniary interest."}],"balance_after":23013754,"source":{"system":"sec-edgar","filing":"0001493152-19-003934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219003934/ownership.xml","form_type":"4"}},{"id":3578365,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152309,"kind":"organization","name":"Don Hankey Trust","position":3,"cik":"0001747743","reported_name":"Don Hankey Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"affiliate of 10% owner/dir"}}],"security":"Common Stock","published_at":"2019-03-26T19:28:09.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":1489362,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Don Hankey Trust (the \"Trust\") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mr. Hankey is the beneficial owner of 25,699,783 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 20,638,298 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the \"Trust\") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital."}],"balance_after":25699783,"source":{"system":"sec-edgar","filing":"0001493152-19-003931","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219003931/ownership.xml","form_type":"4"}},{"id":3578364,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":115034,"kind":"person","name":"Hankey Don","position":1,"cik":"0001561288","reported_name":"Hankey Don","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman of the Board"}},{"id":134448,"kind":"organization","name":"HANKEY CAPITAL, LLC","position":2,"cik":"0001675964","reported_name":"HANKEY CAPITAL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152309,"kind":"organization","name":"Don Hankey Trust","position":3,"cik":"0001747743","reported_name":"Don Hankey Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"affiliate of 10% owner/dir"}}],"security":"Common Stock","published_at":"2019-03-26T19:28:09.000Z","date":"2018-12-17","kind":"purchase","acquired":true,"shares":18009696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Hankey Capital, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares held by Hankey Capital LLC (\"Hankey Capital\") as collateral for the repayment of convertible notes (the \"Notes\") issued to Hankey Capital (the \"Collateral Shares\"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP (\"HIC\") of which the Don Hankey Trust (the \"Trust\") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest."}],"balance_after":24210421,"source":{"system":"sec-edgar","filing":"0001493152-19-003931","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315219003931/ownership.xml","form_type":"4"}},{"id":3984962,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-22T10:05:24.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":60914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 60,914 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person is still providing services to the issuer on the respective date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 60,914 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person is still providing services to the issuer on the respective date."}],"balance_after":77377,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":60914},"source":{"system":"sec-edgar","filing":"0001493152-18-003733","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315218003733/form4.xml","form_type":"4"}},{"id":3987464,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":79579,"kind":"person","name":"Delshad Jim","position":1,"cik":"0001605790","reported_name":"Delshad Jim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2018-03-20T20:12:41.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":26109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four (4) equal quarterly installments over the one year period from the date of grant."}],"balance_after":121442,"derivative":{"exercise_price":1.97,"expiration_date":"2028-01-01","underlying":"Common Stock","underlying_shares":26109},"source":{"system":"sec-edgar","filing":"0001493152-18-003652","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315218003652/form4.xml","form_type":"4"}},{"id":3987463,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":72381,"kind":"person","name":"La Neve Stephen R.","position":1,"cik":"0001644740","reported_name":"La Neve Stephen R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Unit","published_at":"2018-03-20T20:11:06.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":142132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 142,132 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting\nPerson is still providing services to the issuer on the respective date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 142,132 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting\nPerson is still providing services to the issuer on the respective date."}],"balance_after":176546,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":142132},"source":{"system":"sec-edgar","filing":"0001493152-18-003651","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315218003651/form4.xml","form_type":"4"}},{"id":3987462,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":158193,"kind":"person","name":"Booth John J","position":1,"cik":"0001655227","reported_name":"Booth John J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2018-03-20T20:09:31.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":26109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four (4) successive equal quarterly installments over the one year period measured from the date of grant."}],"balance_after":121442,"derivative":{"exercise_price":1.97,"expiration_date":"2028-01-01","underlying":"Common Stock","underlying_shares":26109},"source":{"system":"sec-edgar","filing":"0001493152-18-003650","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315218003650/form4.xml","form_type":"4"}},{"id":3987674,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-20T16:14:13.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":28426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 28,426 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person\nis still providing services to the issuer on the respective date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 28,426 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person\nis still providing services to the issuer on the respective date."}],"balance_after":39530,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":28426},"source":{"system":"sec-edgar","filing":"0001493152-18-003653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315218003653/form4.xml","form_type":"4"}},{"id":4141906,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22193,"kind":"person","name":"Heshmatpour Amir F","position":1,"cik":"0001443035","reported_name":"Heshmatpour Amir F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":81573,"kind":"organization","name":"AFH Holding & Advisory, LLC","position":2,"cik":"0001414636","reported_name":"AFH Holding & Advisory, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-05T21:20:11.000Z","date":"2017-11-29","kind":"other","acquired":true,"shares":915614,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By H&H Funding, LLC"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein."}],"balance_after":2942393,"source":{"system":"sec-edgar","filing":"0001615774-17-007141","document":"s108359_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1443035/000161577417007141/s108359_form4.xml","form_type":"4"}},{"id":4141905,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22193,"kind":"person","name":"Heshmatpour Amir F","position":1,"cik":"0001443035","reported_name":"Heshmatpour Amir F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":81573,"kind":"organization","name":"AFH Holding & Advisory, LLC","position":2,"cik":"0001414636","reported_name":"AFH Holding & Advisory, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-05T21:20:11.000Z","date":"2017-09-07","kind":"other","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By H&H Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported shares reflect the transfer of securities held directly by H&H (Hong Kong) Holdings Co, of which Mr. Heshmatpour is the sole stockholder, to H&H."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein."}],"balance_after":2026779,"source":{"system":"sec-edgar","filing":"0001615774-17-007141","document":"s108359_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1443035/000161577417007141/s108359_form4.xml","form_type":"4"}},{"id":4141904,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22193,"kind":"person","name":"Heshmatpour Amir F","position":1,"cik":"0001443035","reported_name":"Heshmatpour Amir F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":81573,"kind":"organization","name":"AFH Holding & Advisory, LLC","position":2,"cik":"0001414636","reported_name":"AFH Holding & Advisory, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-05T21:20:11.000Z","date":"2017-09-07","kind":"other","acquired":true,"shares":1826779,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By H&H Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares reflect the transfer of shares held directly by AFH Holding & Advisory LLC (\"AFH Holding\") to H&H Funding, LLC (\"H&H\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein."}],"balance_after":1826779,"source":{"system":"sec-edgar","filing":"0001615774-17-007141","document":"s108359_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1443035/000161577417007141/s108359_form4.xml","form_type":"4"}},{"id":4141903,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":22193,"kind":"person","name":"Heshmatpour Amir F","position":1,"cik":"0001443035","reported_name":"Heshmatpour Amir F","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":81573,"kind":"organization","name":"AFH Holding & Advisory, LLC","position":2,"cik":"0001414636","reported_name":"AFH Holding & Advisory, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-05T21:20:11.000Z","date":"2017-09-07","kind":"other","acquired":false,"shares":1826779,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By AFH Holding & Advisory LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares reflect the transfer of shares held directly by AFH Holding & Advisory LLC (\"AFH Holding\") to H&H Funding, LLC (\"H&H\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding."}],"balance_after":1941579,"source":{"system":"sec-edgar","filing":"0001615774-17-007141","document":"s108359_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1443035/000161577417007141/s108359_form4.xml","form_type":"4"}},{"id":4345518,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":158193,"kind":"person","name":"Booth John J","position":1,"cik":"0001655227","reported_name":"Booth John J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2017-04-25T18:43:40.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":26780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four (4) successive equal quarterly installments over the one-year period measured from the date of grant."}],"balance_after":95333,"derivative":{"exercise_price":2.05,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":26780},"source":{"system":"sec-edgar","filing":"0001493152-17-004362","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315217004362/form4.xml","form_type":"4"}},{"id":4347421,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":72381,"kind":"person","name":"La Neve Stephen R.","position":1,"cik":"0001644740","reported_name":"La Neve Stephen R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-21T20:58:06.000Z","date":"2016-05-27","kind":"grant","acquired":true,"shares":538290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 27, 2016, the Reporting Person was granted 538,290 stock option, 1/3 of the shares subject to the option vest on each anniversary of the Vesting Commencement Date, subject to the option holder's Continuous Service (as defined in the Plan) on each vesting date, provided the Reporting Person is still providing services to the Issuer on the respective date."}],"balance_after":2653895,"derivative":{"exercise_price":2.05,"expiration_date":"2026-05-26","underlying":"Common Stock","underlying_shares":538290},"source":{"system":"sec-edgar","filing":"0001493152-17-004285","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315217004285/form4.xml","form_type":"4"}},{"id":4347422,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":79579,"kind":"person","name":"Delshad Jim","position":1,"cik":"0001605790","reported_name":"Delshad Jim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2017-04-21T20:53:04.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":26780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in four (4) successive equal quarterly installments over the one-year period measured from the date of grant."}],"balance_after":95333,"derivative":{"exercise_price":2.05,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":26780},"source":{"system":"sec-edgar","filing":"0001493152-17-004282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315217004282/form4.xml","form_type":"4"}},{"id":4347420,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-21T20:42:54.000Z","date":"2016-05-27","kind":"grant","acquired":true,"shares":269145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 27, 2016, the Reporting Person was granted 269,145 stock options, 1/3 of the shares subject to the option vest on each anniversary of the Vesting Commencement Date, subject to the option holder's Continuous Service (as defined in the Plan) on each vesting date, provided the Reporting Person is still providing services to the Issuer on the respective date."}],"balance_after":1326204,"derivative":{"exercise_price":2.05,"expiration_date":"2026-05-26","underlying":"Common Stock","underlying_shares":269145},"source":{"system":"sec-edgar","filing":"0001493152-17-004280","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315217004280/form4.xml","form_type":"4"}}]}